. Energy News .




.
EPIDEMICS
Health experts, scientists to discuss bird flu studies
by Staff Writers
Geneva (AFP) Feb 10, 2012


The World Health Organization said Friday it will meet next week to determine whether scientists can publish research on a bird flu virus that may be easily passed among humans.

The two-day discussion will relate to research on a mutation of the H5N1 virus that international scientists halted on January 20 citing fears of the devastation it could wreak were it to escape the laboratory.

According to WHO, avian influenza H5N1 is primarily transmitted between birds, and very rarely to humans.

Two separate teams of researchers, one in the Netherlands and the other in the United States, found ways late last year to engineer the H5N1 virus so that it is transmitted among mammals, something that has been rare.

The breakthrough raised alarm that the method could fall into the wrong hands and unleash a massive flu pandemic that could cost millions of lives.

A US advisory panel in December urged that key details remain unpublished.

WHO said it will hold a technical meeting on Wednesday and Thursday on the specific circumstances and results of the two studies.

"There will be 22 participants: two teams of researchers, representatives of the influenza laboratory network and representatives of the scientific newspapers Science and Nature" said WHO spokeswoman Fadela Chaib.

They will try to reach a consensus about practical actions to resolve the most urgent issues, particularly those related to access to and dissemination of the results of this research, WHO said.

Related Links
Epidemics on Earth - Bird Flu, HIV/AIDS, Ebola




.
.
Get Our Free Newsletters Via Email
...
Buy Advertising Editorial Enquiries




.

. Comment on this article via your Facebook, Yahoo, AOL, Hotmail login.

Share this article via these popular social media networks
del.icio.usdel.icio.us DiggDigg RedditReddit GoogleGoogle



EPIDEMICS
S.Africa announces AIDS drug venture with Swiss Lonza
Cape Town (AFP) Feb 10, 2012
South Africa on Friday unveiled plans for a 1.6 billion rand ($208 million, 157 million euro) pharmaceutical plant, in a joint venture with Swiss biochemicals group Lonza to produce anti-AIDS drugs. Lonza, headquartered in Basel, confirmed talks with the South African government but said no deal had yet been inked. "This joint venture, named Ketlaphela, will establish the first pharmaceu ... read more


EPIDEMICS
Deconstructing a Mystery: What Caused Snowmaggedon?

Pleiades captures its first images using e2v sensors

EPIDEMICS
GPS court ruling leaves US phone tracking unclear

Russia May Spend Almost $12 bln on Glonass in 2012-2020

EPIDEMICS
UN recognizes US Girl Scouts for palm oil effort

EPIDEMICS
Study: Mandating ethanol wrong solution

Sustainable land use strategies to support bioenergy

Fuel from market waste

Enerkem and GreenField Ethanol Announce Quebec's First Waste-to-Biofuels Production Facility

EPIDEMICS
Industry welcomes renewed commitment to Solar Flagships program

AORA Solar Launches "Always-On" Solar Power Station in Spain

Solar Inverter Market Hits Speed Bump in 2011

Solarcells work better in two wavelengths

EPIDEMICS
New EU wind power capacity near level

EPIDEMICS
EPIDEMICS
China police officer killed in Tibetan area: state media

Tibetan nun self-immolates in China: rights groups

Chinese village experiments with democracy

Police chief flies to Beijing amid defection rumours


Memory Foam Mattress Review

Newsletters :: SpaceDaily Express :: SpaceWar Express :: TerraDaily Express :: Energy Daily
XML Feeds :: Space News :: Earth News :: War News :: Solar Energy News

.

The content herein, unless otherwise known to be public domain, are Copyright 1995-2012 - Space Media Network. AFP, UPI and IANS news wire stories are copyright Agence France-Presse, United Press International and Indo-Asia News Service. ESA Portal Reports are copyright European Space Agency. All NASA sourced material is public domain. Additional copyrights may apply in whole or part to other bona fide parties. Advertising does not imply endorsement,agreement or approval of any opinions, statements or information provided by Space Media Network on any Web page published or hosted by Space Media Network. Privacy Statement